Robotic Point-of-Care OCT

机器人床旁 OCT

基本信息

  • 批准号:
    10878635
  • 负责人:
  • 金额:
    $ 24.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT The PI was previously funded by the F30 mechanism while completing the Duke Medical Scientist Training Program. He has since completed medical school and internship and now returns for a full-time research career. This career development proposal is an effective continuation of the PI’s prior mentored training and research experience and seeks to develop him into an independent investigator. The proposed project concerns the role of optical coherence tomography (OCT) in retinal disease screening. Preventable retinal blindness affects tens of millions of Americans and hundreds of millions worldwide. Its top three causes are chronic, progressive conditions that yield irreversible vision loss after an initial asymptomatic period. Annual screening is therefore essential to detect and treat these diseases before sight deteriorates. Rates of screening are suboptimal, however, because the proper eye examination is difficult for and inaccurate when performed by primary care providers (PCPs). OCT is an essential imaging modality for management of retinal diseases. Currently, clinical OCT is deployed as bulky tabletop instruments that require trained ophthalmic photographers, dedicated imaging suites, and mechanical head stabilization with chinrests for operation, which has prevented OCT-based eye screening by PCPs. We recently introduced robotic point-of-care OCT (RAOCT) as a fundamentally new paradigm for OCT-based eye examination that overcomes the barriers that restrict OCT to ophthalmology offices. RAOCT offers semi- or fully-automated non-contact OCT imaging by bringing a robot-mounted OCT scanner to the patient, tracking them throughout a large imaging workspace, and optically correcting for motion artifact. Our laboratory prototypes using this approach have demonstrated sufficient OCT quality in freestanding and seated subjects for anatomic measurement and clinical correlation, respectively, with only minimal operator training. These prototypes function reliably only under controlled laboratory conditions, however, and significant technology development for portability, tracking robustness, and motion correction is necessary to yield a clinic- ready instrument. This project therefore seeks to advance our bench-mounted prototypes into fully-fledged mobile systems for imaging in non-specialist clinics and to test them against the OCT standard-of-care. First, we will transition our prototype into a wheeled cart that can be brought into clinics, upgrade our robot arm for extended reach, and redesign our robot-mounted scanner for improved tracking under realistic imaging conditions. Next, we will enhance motion attenuation by transitioning image processing algorithms to dedicated hardware, by adding digital correction for residual motion, and by incorporating a novel adaptive scanning technique to reduce imaging time. Finally, we will perform RAOCT imaging in ophthalmology clinics to compare against the standard of care and in primary care offices to evaluate screening workflows. Completion of this project will develop robotic point-of-care OCT into a turnkey imaging platform that promises to enhance eye screening in primary care settings.
项目总结/摘要 PI之前在完成杜克医学科学家培训时由F30机制资助 程序.此后,他完成了医学院和实习,现在返回全职研究生涯。 该职业发展建议是PI之前指导培训和研究的有效延续 他希望能把自己培养成一名独立的调查员。拟议项目涉及的作用 光学相干断层扫描(OCT)在视网膜疾病筛查中的应用。可摘性视网膜盲影响数十人 数以百万计的美国人和全世界数以亿计的人。其前三大原因是慢性的、进行性的 在最初的无症状期后产生不可逆视力丧失的病症。因此,年度筛查 在视力恶化之前发现和治疗这些疾病至关重要。筛查率不理想, 然而,由于适当的眼睛检查是困难的和不准确的,当进行初级保健 供应商(PCP)。OCT是用于视网膜疾病管理的基本成像模式。目前,临床 OCT作为笨重的台式仪器部署,需要经过培训的眼科摄影师、专用成像 套房,以及手术用下巴托的机械头部稳定,这阻止了基于OCT的眼睛 通过PCP筛选。我们最近推出了机器人床旁OCT(RAOCT),作为一种全新的 这是基于OCT的眼科检查的范例,克服了限制OCT进入眼科诊所的障碍。 RAOCT提供半自动或全自动非接触式OCT成像,通过将机器人安装的OCT扫描仪 患者,在整个大的成像工作空间中跟踪他们,并光学校正运动伪影。我们 使用这种方法的实验室原型已经证明在独立式和坐式中具有足够的OCT质量 分别用于解剖测量和临床相关性的受试者,仅接受最低限度的操作员培训。 然而,这些原型仅在受控的实验室条件下可靠地运行, 便携性、跟踪鲁棒性和运动校正的技术开发是必要的, 准备好的仪器因此,该项目旨在将我们的台式原型推进到成熟的 用于非专科诊所成像的移动的系统,并根据OCT护理标准对其进行测试。一是 我们将把我们的原型转变成一个可以带进诊所的轮式推车,升级我们的机器人手臂, 扩展范围,并重新设计我们的机器人安装扫描仪,以改善逼真成像下的跟踪 条件接下来,我们将通过将图像处理算法过渡到专用的 硬件,通过增加残余运动的数字校正,并通过结合一种新的自适应扫描 减少成像时间的技术。最后,我们将在眼科诊所进行RAOCT成像, 对照护理标准和初级保健办公室评估筛查工作流程。完成本 一个项目将把机器人床旁OCT开发成一个交钥匙成像平台, 在初级保健机构进行筛查。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark Draelos其他文献

Mark Draelos的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark Draelos', 18)}}的其他基金

Robotic Point-of-Care OCT
机器人床旁 OCT
  • 批准号:
    10507461
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
Arbitrary Viewpoint Robotic Surgery
任意视角机器人手术
  • 批准号:
    9330681
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    $ 24.9万
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    $ 24.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了